VEGF121/MAP30 fusion toxin (Shanxi Kangbao Biological Products)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameVEGF121/MAP30 fusion toxin (Shanxi Kangbao Biological Products)
Drug Alias NameVEGF121 fusion toxin (Shanxi Kangbao Biological Products)anticancer angiogenesis inhibitor (Shanxi Kangbao Biological Products)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Toxin
Mechanisms of ActionVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShanxi Kangbao Biological Product Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanxi Kangbao Biological Product Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A